These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8431206)

  • 1. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis.
    Lohmander LS; Hoerrner LA; Lark MW
    Arthritis Rheum; 1993 Feb; 36(2):181-9. PubMed ID: 8431206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury.
    Lohmander LS; Hoerrner LA; Dahlberg L; Roos H; Björnsson S; Lark MW
    J Rheumatol; 1993 Aug; 20(8):1362-8. PubMed ID: 8230020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus.
    Lohmander LS; Roos H; Dahlberg L; Hoerrner LA; Lark MW
    J Orthop Res; 1994 Jan; 12(1):21-8. PubMed ID: 8113939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage metabolism in the injured and uninjured knee of the same patient.
    Dahlberg L; Roos H; Saxne T; Heinegård D; Lark MW; Hoerrner LA; Lohmander LS
    Ann Rheum Dis; 1994 Dec; 53(12):823-7. PubMed ID: 7864691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture--synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1.
    Dahlberg L; Fridén T; Roos H; Lark MW; Lohmander LS
    Br J Rheumatol; 1994 Dec; 33(12):1107-11. PubMed ID: 8000736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.
    Lohmander LS; Saxne T; Heinegård DK
    Ann Rheum Dis; 1994 Jan; 53(1):8-13. PubMed ID: 8311563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.
    Hembry RM; Bagga MR; Reynolds JJ; Hamblen DL
    Ann Rheum Dis; 1995 Jan; 54(1):25-32. PubMed ID: 7880117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.
    Walakovits LA; Moore VL; Bhardwaj N; Gallick GS; Lark MW
    Arthritis Rheum; 1992 Jan; 35(1):35-42. PubMed ID: 1370619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of collagenase, tissue inhibitor of metalloproteinases-1 (TIMP-1), collagenase approximately TIMP-1 complexes and glycosaminoglycan (GAG) in sequential samples of synovial fluid aspirated from patients with osteoarthritis.
    Cawston TE; Curry V; Ramsey S; Clark IM; Kyle VA; Adebajo A; Silverman B; Daymond T; Hazleman BL
    Clin Exp Rheumatol; 1995; 13(4):431-7. PubMed ID: 7586773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid.
    Shinmei M; Kobayashi T; Yoshihara Y; Samura A
    J Rheumatol Suppl; 1995 Feb; 43():78-81. PubMed ID: 7752146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
    Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
    Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of increased levels of proteoglycan fragments in synovial fluid (SF) and increased levels of stromelysin in cartilage, synovium and SF by intraarticular injection of canine monocyte conditioned medium into dogs.
    Lark MW; MacNaul KA; Donatelli S; McDonnell J; Hoerrner LA; Stevens KA; Saphos CA; Bayne EK; Hutchinson NI; Moore VL
    J Rheumatol; 1994 Sep; 21(9):1716-24. PubMed ID: 7799356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased concentrations of bone sialoprotein in joint fluid after knee injury.
    Lohmander LS; Saxne T; Heinegård D
    Ann Rheum Dis; 1996 Sep; 55(9):622-6. PubMed ID: 8882132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella.
    Väätäinen U; Lohmander LS; Thonar E; Hongisto T; Agren U; Rönkkö S; Jaroma H; Kosma VM; Tammi M; Kiviranta I
    Osteoarthritis Cartilage; 1998 Mar; 6(2):115-24. PubMed ID: 9692066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation.
    Chockalingam PS; Glasson SS; Lohmander LS
    Osteoarthritis Cartilage; 2013 Feb; 21(2):339-45. PubMed ID: 23142724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease.
    Heinegård D; Inerot S; Wieslander J; Lindblad G
    Scand J Clin Lab Invest; 1985 Sep; 45(5):421-7. PubMed ID: 4035279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise.
    Roos H; Dahlberg L; Hoerrner LA; Lark MW; Thonar EJ; Shinmei M; Lindqvist U; Lohmander LS
    Osteoarthritis Cartilage; 1995 Mar; 3(1):7-14. PubMed ID: 7719956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.